FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Douglas Jabs

Research Profile

Disorders

Physiology

Visual Acuity

Chemicals & Drugs

Concepts & Ideas

Procedures

Anatomy

CD4-Positive T-Lymphocytes

Living Beings

Cytomegalovirus

Co-author Network

Publications

TOP 3
Sapna Gangaputra; Douglas A Jabs; Alice T Lyon; Jennifer E Thorne; Vijay Vaidya; Lea Drye
Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome.
Anthony C Gregory; Douglas A Jabs; R Oktay Kaçmaz; John H Kempen; Grace Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne; Ebenezer Daniel; C Stephen Foster
Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study.
Brian Lehpamer; Erin Laverne Moshier; Jessica Ackert; James Godbold; Naomi Goldberg; Douglas A Jabs
Subretinal fluid in uveitic macular edema: effect on vision and response to therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Douglas Jabs (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sapna Gangaputra; Douglas A Jabs; Alice T Lyon; Jennifer E Thorne; Vijay Vaidya; Lea Drye
Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome.
American journal of ophthalmology 2013;155(2):206-212.e5.
2013: Anthony C Gregory; Douglas A Jabs; R Oktay Kaçmaz; John H Kempen; Grace Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne; Ebenezer Daniel; C Stephen Foster
Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study.
Ophthalmology 2013;120(1):186-92.
2013: Brian Lehpamer; Erin Laverne Moshier; Jessica Ackert; James Godbold; Naomi Goldberg; Douglas A Jabs
Subretinal fluid in uveitic macular edema: effect on vision and response to therapy.
American journal of ophthalmology 2013;155(1):143-9.
2012: Douglas A Jabs
Regional corticosteroids for scleritis.
Ophthalmology 2012;119(10):2198-2199.e1; author reply 2199-200.
2012: Andrea D Branch; Douglas T Dieterich; Douglas A Jabs; Curtis L Meinert; Marie-Louise Vachon; Mark L Van Natta
Mortality in hepatitis C virus-infected patients with a diagnosis of AIDS in the era of combination antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55(1):137-44.
2012: Elizabeth Sugar; Jennifer E Thorne; Alka Ahuja; Ronald P Danis; Douglas A Jabs; Curtis L Meinert
Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
American journal of ophthalmology 2012;153(6):1016-24.e5.
2012: Leon D Charkoudian; C Stephen Foster; Sapna Gangaputra; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; Siddharth S Pujari; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne; Gui-Shuang Ying; John H Kempen
High-dose intravenous corticosteroids for ocular inflammatory diseases.
Ocular immunology and inflammation 2012;20(2):91-9.
2011: Janet T Holbrook; Douglas A Jabs; John H Kempen; Nancy A Prusakowski; Michael M Altaweel
Challenges in the design and implementation of the Multicenter Uveitis Steroid Treatment (MUST) Trial--lessons for comparative effectiveness trials.
Clinical trials (London, England) 2011;8(6):736-43.
2011: Elizabeth Sugar; Jennifer E Thorne; Albert T Vitale; Nisha Acharya; Michael M Altaweel; Douglas A Jabs; Sue Lightman
Identifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomography.
American journal of ophthalmology 2011;152(6):1044-1052.e5.
2011: Janet T Holbrook; Douglas A Jabs; Jennifer E Thorne; Mark L Van Natta; Mark Bardsley; Ryan Colvin
Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis.
American journal of ophthalmology 2011;152(4):628-637.e1.
2011: Henry A Leder; James P Dunn; Anat Galor; Douglas A Jabs; Jennifer E Thorne
Periocular triamcinolone acetonide injections for cystoid macular edema complicating noninfectious uveitis.
American journal of ophthalmology 2011;152(3):441-448.e2.
2011: Jennifer E Thorne; Mark L Van Natta; Douglas A Jabs; Jacque L Duncan; Sunil K Srivastava
Visual field loss in patients with cytomegalovirus retinitis.
Ophthalmology 2011;118(5):895-901.
2011: Nishi Gulati; Farzin Forooghian; Ronni Lieberman; Douglas A Jabs
Vascular endothelial growth factor inhibition in uveitis: a systematic review.
The British journal of ophthalmology 2011;95(2):162-5.
2010: Douglas A Jabs; Alka Ahuja; Mark L Van Natta; Alice Lyon; Sunil Srivastava; Sapna Gangaputra
Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes.
Ophthalmology 2010;117(11):2152-61.e1-2.
2010: Anat Galor; William Feuer; John H Kempen; R Oktay Kaçmaz; Teresa L Liesegang; Eric B Suhler; C Stephen Foster; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; Jennifer E Thorne
Adverse effects of smoking on patients with ocular inflammation.
The British journal of ophthalmology 2010;94(7):848-53.
2010: Jennifer E Thorne; Fasika A Woreta; James P Dunn; Douglas A Jabs
Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids.
Ophthalmology 2010;117(7):1436-41.
2010: Gary N Holland; Peter J Kappel; Mark L Van Natta; Frank J Palella; Alice T Lyon; Kayur H Shah; Peter R Pavan; Douglas A Jabs
Association between abnormal contrast sensitivity and mortality among people with acquired immunodeficiency syndrome.
American journal of ophthalmology 2010;149(5):807-16.
2010: Douglas A Jabs; Barbara K Martin; Michael S Forman
Mortality associated with resistant cytomegalovirus among patients with cytomegalovirus retinitis and AIDS.
Ophthalmology 2010;117(1):128-132.e2.
2009: Marie-Lyne Bélair; Stephen J Kim; Jennifer E Thorne; James P Dunn; Sanjay R Kedhar; Diane M Brown; Douglas A Jabs
Incidence of cystoid macular edema after cataract surgery in patients with and without uveitis using optical coherence tomography.
American journal of ophthalmology 2009;148(1):128-35.e2.
2008: Jennifer E Thorne; Fasika A Woreta; Douglas A Jabs; Grant J Anhalt
Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy.
Ophthalmology 2008;115(12):2146-2152.e1.
2008: Anat Galor; Douglas A Jabs; Henry A Leder; Sanjay R Kedhar; James P Dunn; George B Peters; Jennifer E Thorne
Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation.
Ophthalmology 2008;115(10):1826-32.
2008: Stephen J Kim; Marie-Lyne Belair; Neil M Bressler; James P Dunn; Jennifer E Thorne; Sanjay R Kedhar; Douglas A Jabs
A method of reporting macular edema after cataract surgery using optical coherence tomography.
Retina (Philadelphia, Pa.) 2008;28(6):870-6.
2008: Jennifer E Thorne; Ebenezer Daniel; Douglas A Jabs; Sanjay R Kedhar; George B Peters; James P Dunn
Smoking as a risk factor for cystoid macular edema complicating intermediate uveitis.
American journal of ophthalmology 2008;145(5):841-6.
2008: Stephen J Kim; NA Adams; Hassanain S Toma; Marie-Lyne Belair; Jennifer E Thorne; W Richard Green; Douglas A Jabs
Safety of intravitreal ketorolac and diclofenac: an electroretinographic and histopathologic study.
Retina (Philadelphia, Pa.) 2008;28(4):595-605.
2008: Mark A Jacobson; Qi Xuan Tan; Valerie Girling; C Poon; Mark L Van Natta; Douglas A Jabs; Margaret Inokuma; Holden T Maecker; Barry M Bredt; Elizabeth Sinclair
Poor predictive value of cytomegalovirus (CMV)-specific T cell assays for the development of CMV retinitis in patients with AIDS.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(3):458-66.
2008: Jennifer E Thorne; Douglas A Jabs; Sanjay R Kedhar; George B Peters; James P Dunn
Loss of visual field among patients with birdshot chorioretinopathy.
American journal of ophthalmology 2008;145(1):23-28.
2007: Sanjay R Kedhar; Douglas A Jabs
Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Herpes : the journal of the IHMF 2007;14(3):66-71.
2007: Douglas A Jabs; Robert A Prendergast; Adam L Campbell; Bella Lee; Esen Karamursel Akpek; Hervé C Gérard; Alan P Hudson; Judith A Whittum-Hudson
Autoimmune Th2-mediated dacryoadenitis in MRL/MpJ mice becomes Th1-mediated in IL-4 deficient MRL/MpJ mice.
Investigative ophthalmology & visual science 2007;48(12):5624-9.
2007: Sanjay R Kedhar; Jennifer E Thorne; Susan Wittenberg; James P Dunn; Douglas A Jabs
Multifocal choroiditis with panuveitis and punctate inner choroidopathy: comparison of clinical characteristics at presentation.
Retina (Philadelphia, Pa.) 2007;27(9):1174-9.
2007: MARTA GILSON; Neil M Bressler; Douglas A Jabs; Sharon D Solomon; Jennifer E Thorne; David J Wilson
Periocular triamcinolone and photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration.
Ophthalmology 2007;114(9):1713-21.
2007: Adam T Gerstenblith; Jennifer E Thorne; Lucia Sobrin; Diana V Do; Syed Mahmood Shah; C Stephen Foster; Douglas A Jabs; Quan Dong Nguyen
Punctate inner choroidopathy: a survey analysis of 77 persons.
Ophthalmology 2007;114(6):1201-4.
2007: Jennifer E Thorne; Fasika Woreta; Sanjay R Kedhar; James P Dunn; Douglas A Jabs
Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss.
American journal of ophthalmology 2007;143(5):840-846.
2007: Jennifer E Thorne; Susan Wittenberg; Sanjay R Kedhar; James P Dunn; Douglas A Jabs
Optic neuropathy complicating multifocal choroiditis and panuveitis.
American journal of ophthalmology 2007;143(4):721-3.
2007: Barbara K Martin; Michelle O Ricks; Michael S Forman; Douglas A Jabs
Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(7):1001-8.
2007: Douglas A Jabs; Mark L Van Natta; Janet T Holbrook; John H Kempen; Curtis L Meinert; Matthew D Davis
Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment.
Ophthalmology 2007;114(4):780-6.
2007: Fasika Woreta; Jennifer E Thorne; Douglas A Jabs; Sanjay R Kedhar; James P Dunn
Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis.
American journal of ophthalmology 2007;143(4):647-55.
2007: Douglas A Jabs; Mark L Van Natta; Janet T Holbrook; John H Kempen; Curtis L Meinert; Matthew D Davis
Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment.
Ophthalmology 2007;114(4):787-93.
2007: Jennifer E Thorne; Janet T Holbrook; Douglas A Jabs; John H Kempen; Charles Nichols; Curtis L Meinert
Effect of cytomegalovirus retinitis on the risk of visual acuity loss among patients with AIDS.
Ophthalmology 2007;114(3):591-8.
2006: Jennifer E Thorne; Susan Wittenberg; Douglas A Jabs; George B Peters; Terry L Reed; Sanjay R Kedhar; James P Dunn
Multifocal choroiditis with panuveitis incidence of ocular complications and of loss of visual acuity.
Ophthalmology 2006;113(12):2310-6.
2006: Jennifer E Thorne; Grant J Anhalt; Douglas A Jabs; Zenaida de la Cruz; W Richard Green
Role of electron microscopy in the diagnosis of ocular mucous membrane pemphigoid.
Ophthalmology 2006;113(9):1651-6.
2006: Ebenezer Daniel; Sapna Gangaputra; John H Kempen; Douglas A Jabs
Recurrent nodular scleritis preceding an adult TINU syndrome.
Ocular immunology and inflammation 2006;14(4):239-40.
2006: Jennifer E Thorne; Douglas A Jabs; John H Kempen; Janet T Holbrook; Charles Nichols; Curtis L Meinert
Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Ophthalmology 2006;113(8):1441-5.
2006: Jennifer E Thorne; Douglas A Jabs; John H Kempen; Janet T Holbrook; Charles Nichols; Curtis L Meinert
Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Ophthalmology 2006;113(8):1432-40.
2006: Douglas A Jabs; Barbara K Martin; Michelle O Ricks; Michael S Forman
Detection of ganciclovir resistance in patients with AIDS and cytomegalovirus retinitis: correlation of genotypic methods with viral phenotype and clinical outcome.
The Journal of infectious diseases 2006;193(12):1728-37.
2006: John H Kempen; Yuan-I Min; William R Freeman; Gary N Holland; Dorothy N Friedberg; Douglas T Dieterich; Douglas A Jabs
Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis.
Ophthalmology 2006;113(4):684-94.
2005: Irina Bykhovskaya; Jennifer E Thorne; John H Kempen; James P Dunn; Douglas A Jabs
Vogt-Koyanagi-Harada disease: clinical outcomes.
American journal of ophthalmology 2005;140(4):674-8.
2005: James P Dunn; Andrea Yamashita; John H Kempen; Douglas A Jabs
Retinal vascular occlusion in patients infected with human immunodeficiency virus.
Retina (Philadelphia, Pa.) 2005;25(6):759-66.
2005: Douglas A Jabs; Barbara K Martin; Michael S Forman; Michelle O Ricks
Cytomegalovirus (CMV) blood DNA load, CMV retinitis progression, and occurrence of resistant CMV in patients with CMV retinitis.
The Journal of infectious diseases 2005;192(4):640-9.
2005: Jennifer E Thorne; Douglas A Jabs; faqir ahmad qazi; Quan Dong Nguyen; John H Kempen; James P Dunn
Mycophenolate mofetil therapy for inflammatory eye disease.
Ophthalmology 2005;112(8):1472-7.
2005: Jennifer E Thorne; Douglas A Jabs; George B Peters; David Hair; James P Dunn; John H Kempen
Birdshot retinochoroidopathy: ocular complications and visual impairment.
American journal of ophthalmology 2005;140(1):45-51.
2005: John H Kempen; Douglas A Jabs; Laura A Wilson; James P Dunn; Sheila K West
Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis.
American journal of ophthalmology 2005;139(6):1028-34.
2005: Douglas A Jabs; Janet T Holbrook; Mark L Van Natta; Rebecca Clark; Mark A Jacobson; John H Kempen; Robert L Murphy
Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy.
Ophthalmology 2005;112(5):771-9.
2005: David V Weinberg; Janet T Holbrook; Larry D Hubbard; Matthew D Davis; Douglas A Jabs; Gary N Holland
Clinician versus reading center assessment of cytomegalovirus retinitis lesion size.
Ophthalmology 2005;112(4):559-66.
2005: Jennifer E Thorne; Kayur H Shah; Diane M Brown; Gary N Holland; Douglas A Jabs
Posterior intracorneal opacities in patients with HIV infection.
Ocular immunology and inflammation 2005;13(1):25-31.
2005: Douglas A Jabs; Esen Karamursel Akpek
Immunosuppression for posterior uveitis.
Retina (Philadelphia, Pa.) 2005;25(1):1-18.
2004: Douglas A Jabs; Mark L Van Natta; Jennifer E Thorne; David V Weinberg; Travis Meredith; Baruch D Kuppermann; Kent A Sepkowitz; Helen K Li
Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment.
Ophthalmology 2004;111(12):2232-9.
2004: Douglas A Jabs; Mark L Van Natta; Jennifer E Thorne; David V Weinberg; Travis Meredith; Baruch D Kuppermann; Kent A Sepkowitz; Helen K Li
Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression.
Ophthalmology 2004;111(12):2224-31.
2004: Irene C Kuo; John H Kempen; James P Dunn; Georgia B Vogelsang; Douglas A Jabs
Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection.
American journal of ophthalmology 2004;138(3):338-46.
2004: Douglas A Jabs; Hervé C Gérard; Yuewang Wei; Adam L Campbell; Alan P Hudson; Esen Karamursel Akpek; Bella Lee; Robert A Prendergast; Judith A Whittum-Hudson
Inflammatory mediators in autoimmune lacrimal gland disease in MRL/Mpj mice.
Investigative ophthalmology & visual science 2004;45(7):2293-8.
2004: Esen Karamursel Akpek; Jennifer E Thorne; faqir ahmad qazi; Diana V Do; Douglas A Jabs
Evaluation of patients with scleritis for systemic disease.
Ophthalmology 2004;111(3):501-6.
2004: Larry D Hubbard; Michelle O Ricks; Barbara K Martin; Neil M Bressler; John H Kempen; James P Dunn; Douglas A Jabs
Comparability of two fundus photograph reading centers in grading cytomegalovirus retinitis progression.
American journal of ophthalmology 2004;137(3):426-34.
2004: James P Dunn; Mark L Van Natta; Gregory Foster; Baruch D Kuppermann; Daniel F Martin; Alice Zong; Douglas A Jabs
Complications of ganciclovir implant surgery in patients with cytomegalovirus retinitis: the Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial.
Retina (Philadelphia, Pa.) 2004;24(1):41-50.
2004: Jennifer E Thorne; Grant J Anhalt; Douglas A Jabs
Mucous membrane pemphigoid and pseudopemphigoid.
Ophthalmology 2004;111(1):45-52.
2004: Esen Karamursel Akpek; Douglas A Jabs; Hervé C Gérard; Robert A Prendergast; Alan P Hudson; Bella Lee; Judith A Whittum-Hudson
Chemokines in autoimmune lacrimal gland disease in MRL/MpJ mice.
Investigative ophthalmology & visual science 2004;45(1):185-90.
2003: John H Kempen; Douglas A Jabs; Laura A Wilson; James P Dunn; Sheila K West; James Tonascia
Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(10):1365-73.
2003: faqir ahmad qazi; Jennifer E Thorne; Douglas A Jabs
Scleral nodule associated with sarcoidosis.
American journal of ophthalmology 2003;136(4):752-4.
2003: Jennifer E Thorne; Douglas A Jabs; Olga V Nikolskaia; Daniel Mimouni; Grant J Anhalt; H Carlos Nousari
Lichen planus and cicatrizing conjunctivitis: characterization of five cases.
American journal of ophthalmology 2003;136(2):239-43.
2003: John H Kempen; Barbara K Martin; Albert W Wu; Bruce Barron; Jennifer E Thorne; Douglas A Jabs
The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy.
Ophthalmology 2003;110(5):987-95.
2003: John H Kempen; Douglas A Jabs; Laura A Wilson; James P Dunn; Sheila K West; James Tonascia
Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome.
Archives of ophthalmology 2003;121(4):466-76.
2003: Adriana Weinberg; Douglas A Jabs; Sunwen Chou; Barbara K Martin; Nell S Lurain; Michael S Forman; Clyde S Crumpacker
Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis.
The Journal of infectious diseases 2003;187(5):777-84.
2003: Adele M Kaplan Gilpin; Janet T Holbrook; Douglas A Jabs; Curtis L Meinert
Data and safety monitoring board deliberations resulting in the early termination of the Monoclonal Antibody Cytomegalovirus Retinitis Trial.
Controlled clinical trials 2003;24(1):92-8.
2003: Janet T Holbrook; Douglas A Jabs; David V Weinberg; Richard Alan Lewis; Matthew D Davis; Dorothy Friedberg
Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active antiretroviral therapy.
Archives of ophthalmology 2003;121(1):99-107.
2003: Douglas A Jabs; Barbara K Martin; Michael S Forman; Larry D Hubbard; James P Dunn; John H Kempen; Janet L Davis; David V Weinberg
Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis.
American journal of ophthalmology 2003;135(1):26-34.
2002: Jennifer E Thorne; Douglas A Jabs; Olga V Nikolskaia; Grant J Anhalt; H Carlos Nousari
Discoid lupus erythematosus and cicatrizing conjunctivitis: clinicopathologic study of two cases.
Ocular immunology and inflammation 2002;10(4):287-92.
2002: Paul A Latkany; Douglas A Jabs; Justine R Smith; James T Rosenbaum; Howard H Tessler; Ivan R Schwab; R Christopher Walton; Jennifer E Thorne; Albert M Maguire
Multifocal choroiditis in patients with familial juvenile systemic granulomatosis.
American journal of ophthalmology 2002;134(6):897-904.
2002: Michael Davidson; Yuan-I Min; Janet T Holbrook; Mark L Van Natta; Thomas C Quinn; Robert L Murphy; William Welch; Douglas A Jabs; Curtis L Meinert
Influence of filgrastim (granulocyte colony-stimulating factor) on human immunodeficiency virus type 1 RNA in patients with cytomegalovirus retinitis.
The Journal of infectious diseases 2002;186(7):1013-8.
2002: Esen Karamursel Akpek; Douglas A Jabs; Howard H Tessler; Brian C Joondeph; C Stephen Foster
Successful treatment of serpiginous choroiditis with alkylating agents.
Ophthalmology 2002;109(8):1506-13.
2002: Douglas A Jabs; Adele M Kaplan Gilpin; Yuan-I Min; Alejo Erice; John H Kempen; Thomas C Quinn
HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis Trial.
AIDS (London, England) 2002;16(6):877-87.
2002: Huiling Hu; Douglas A Jabs; Michael S Forman; Barbara K Martin; James P Dunn; David V Weinberg; Janet L Davis
Comparison of cytomegalovirus (CMV) UL97 gene sequences in the blood and vitreous of patients with acquired immunodeficiency syndrome and CMV retinitis.
The Journal of infectious diseases 2002;185(7):861-7.
2002: Michael Davidson; Yuan-I Min; Janet T Holbrook; Mark L Van Natta; Robert Murphy; Douglas A Jabs; William Welch; Curtis L Meinert
Use of filgrastim as adjuvant therapy in patients with AIDS-related cytomegalovirus retinitis.
AIDS (London, England) 2002;16(5):757-65.
2002: Douglas A Jabs; Robert A Prendergast; Judith A Whittum-Hudson
Pathogenesis of autoimmune lacrimal gland disease in MRL/MPJ mice.
Advances in experimental medicine and biology 2002;506(Pt B):771-6.
2002: Douglas A Jabs; Mark L Van Natta; John H Kempen; Peter Reed Pavan; Jennifer I Lim; Robert L Murphy; Larry D Hubbard
Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
American journal of ophthalmology 2002;133(1):48-61.
2001: Douglas A Jabs; Barbara K Martin; Michael S Forman; James P Dunn; Janet L Davis; David V Weinberg; K K Biron; F Baldanti; H Hu
Longitudinal observations on mutations conferring ganciclovir resistance in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis: The Cytomegalovirus and Viral Resistance Study Group Report Number 8.
American journal of ophthalmology 2001;132(5):700-10.
2001: Douglas A Jabs; Robert A Prendergast; E M Rorer; Alan P Hudson; Judith A Whittum-Hudson
Cytokines in autoimmune lacrimal gland disease in MRL/MpJ mice.
Investigative ophthalmology & visual science 2001;42(11):2567-71.
2001: Barbara K Martin; A M Kaplan Gilpin; Douglas A Jabs; Albert W Wu
Reliability, validity, and responsiveness of general and disease-specific quality of life measures in a clinical trial for cytomegalovirus retinitis.
Journal of clinical epidemiology 2001;54(4):376-86.
2001: Janet T Holbrook; Curtis L Meinert; Mark L Van Natta; M Davis; Larry D Hubbard; Douglas A Jabs
Photographic measures of cytomegalovirus retinitis as surrogates for visual outcomes in treated patients.
Archives of ophthalmology 2001;119(4):554-63.
2001: Janet T Holbrook; Curtis L Meinert; Douglas A Jabs
Patient notification and follow-up after suspension of treatment protocols. experience from four clinical trials of treatments for AIDS-related CMV retinitis.
Controlled clinical trials 2001;22(1):62-8.
2001: Douglas A Jabs; Bella Lee; Judith A Whittum-Hudson; Robert A Prendergast
The role of Fas-Fas ligand-mediated apoptosis in autoimmune lacrimal gland disease in MRL/MpJ mice.
Investigative ophthalmology & visual science 2001;42(2):399-401.
2001: Douglas A Jabs; Barbara K Martin; Michael S Forman; James P Dunn; Janet L Davis; David V Weinberg; K K Biron; F Baldanti
Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis.
The Journal of infectious diseases 2001;183(2):333-337.
2001: John H Kempen; Douglas A Jabs; James P Dunn; Sheila K West; James Tonascia
Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome.
Archives of ophthalmology 2001;119(1):33-40.
2000: Douglas A Jabs; James T Rosenbaum; C Stephen Foster; Gary N Holland; G J Jaffe; J S Louie; Robert B Nussenblatt; E R Stiehm; Howard H Tessler; R N Van Gelder; S M Whitcup; D Yocum
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.
American journal of ophthalmology 2000;130(4):492-513.
2000: Douglas A Jabs; A Mudun; James P Dunn; Marta J Marsh
Episcleritis and scleritis: clinical features and treatment results.
American journal of ophthalmology 2000;130(4):469-76.
2000: Janet T Holbrook; Matthew D Davis; Larry D Hubbard; Barbara K Martin; Gary N Holland; Douglas A Jabs; A K Gilpin; Curtis L Meinert; D S Reshef
Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Studies of Ocular Complications of AIDS Research Group.
Archives of ophthalmology 2000;118(9):1196-204.
2000: Quan Dong Nguyen; John H Kempen; S G Bolton; James P Dunn; Douglas A Jabs
Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy.
American journal of ophthalmology 2000;129(5):634-9.
2000: Douglas A Jabs; Bella Lee; Judith A Whittum-Hudson; Robert A Prendergast
Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice.
Investigative ophthalmology & visual science 2000;41(3):826-31.
1999: Douglas A Jabs; M Forman; Cheryl Enger; J Brooks Jackson
Comparison of cytomegalovirus loads in plasma and leukocytes of patients with cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study Group.
Journal of clinical microbiology 1999;37(5):1431-5.
1999: Sharath C Raja; Douglas A Jabs; James P Dunn; Sharon Fekrat; C H Machan; Marta J Marsh; Neil M Bressler
Pars planitis: clinical features and class II HLA associations.
Ophthalmology 1999;106(3):594-9.
1998: Jennifer E Thorne; Douglas A Jabs; Susan Vitale; T Miller; James P Dunn; Richard D Semba
Catheter complications in AIDS patients treated for cytomegalovirus retinitis.
AIDS (London, England) 1998;12(17):2321-7.
1998: Douglas A Jabs; S G Bolton; James P Dunn; A G Palestine
Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy.
American journal of ophthalmology 1998;126(6):817-22.
1998: Douglas A Jabs; Cheryl Enger; James P Dunn; M Forman; Larry D Hubbard
Cytomegalovirus retinitis and viral resistance: 3. Culture results. CMV Retinitis and Viral Resistance Study Group.
American journal of ophthalmology 1998;126(4):543-9.
1998: Douglas A Jabs; Cheryl Enger; M Forman; James P Dunn
Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study Group.
Antimicrobial agents and chemotherapy 1998;42(9):2240-4.
1998: Richard J Whitley; M A Jacobson; Dorothy N Friedberg; Gary N Holland; Douglas A Jabs; D T Dieterich; W David Hardy; M A Polis; T A Deutsch; J Feinberg; S A Spector; S Walmsley; W Lawrence Drew; William G Powderly; P D Griffiths; Constance A Benson; Harold A Kessler
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA.
Archives of internal medicine 1998;158(9):957-69.
1998: Douglas A Jabs; Cheryl Enger; James P Dunn; M Forman
Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. CMV Retinitis and Viral Resistance Study Group.
The Journal of infectious diseases 1998;177(3):770-3.
1997: M L Tay-Kearney; Cheryl Enger; Richard D Semba; Walter III Royal; James P Dunn; Douglas A Jabs
T cell subsets and cytomegalovirus retinitis in human immunodeficiency virus-infected patients.
The Journal of infectious diseases 1997;176(3):790-4.
1997: Douglas A Jabs; Bella Lee; Robert A Prendergast
Role of T cells in the pathogenesis of autoimmune lacrimal gland disease in MRL/Mp-lpr/lpr mice.
Current eye research 1997;16(9):909-16.
1997: I A Shalaby; James P Dunn; Richard D Semba; Douglas A Jabs
Syphilitic uveitis in human immunodeficiency virus-infected patients.
Archives of ophthalmology 1997;115(4):469-73.
1997: A J Mueller; M A Jacobson; S Hurwitz; E L Chuang; Dorothy N Friedberg; S J Haidt; M H Heinemann; Douglas A Jabs; H J Kaplan; W R Freeman
Re-evaluation of time to progression of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients clinically resistant to ganciclovir.
AIDS (London, England) 1997;11(3):397-9.
1997: Cheryl Enger; Douglas A Jabs; James P Dunn; M S Forman; Neil M Bressler; Joseph B Margolick; PATRICIA CHARACHE
Viral resistance and CMV retinitis: design and methods of a prospective study. CRVR Research Groups. Cytomegalovirus Retinitis Viral Resistance Research Group.
Ophthalmic epidemiology 1997;4(1):41-8.
1996: M L Tay-Kearney; Douglas A Jabs
Ophthalmic complications of HIV infection.
The Medical clinics of North America 1996;80(6):1471-92.
1996: Albert W Wu; L C Coleson; Janet T Holbrook; Douglas A Jabs
Measuring visual function and quality of life in patients with cytomegalovirus retinitis. Development of a questionnaire. Studies of Ocular Complication of AIDS Research Group.
Archives of ophthalmology 1996;114(7):841-7.
1996: Douglas A Jabs; James P Dunn; Cheryl Enger; M Forman; Neil M Bressler; PATRICIA CHARACHE
Cytomegalovirus retinitis and viral resistance. Prevalence of resistance at diagnosis, 1994. Cytomegalovirus Retinitis and Viral Resistance Study Group.
Archives of ophthalmology 1996;114(7):809-14.
1996: Douglas A Jabs; B Lee; CAROL BUREK; AM Saboori; Robert A Prendergast
Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL/Mp-lpr/lpr mice.
Investigative ophthalmology & visual science 1996;37(2):377-83.
1996: M L Tay-Kearney; Douglas A Jabs
Treatment of CMV retinopathy in patients with AIDS.
Ocular immunology and inflammation 1996;4(2):113-8.
1996: M L Tay-Kearney; B L Schwam; C Lowder; James P Dunn; D M Meisler; Susan Vitale; Douglas A Jabs
Clinical features and associated systemic diseases of HLA-B27 uveitis.
American journal of ophthalmology 1996;121(1):47-56.
1996: Douglas A Jabs; W H Burns; Robert A Prendergast
Paradoxic effect of anti-CD4 therapy on lacrimal gland disease in MRL/Mp-lpr/lpr mice.
Investigative ophthalmology & visual science 1996;37(1):246-50.
1995: Douglas A Jabs
Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
Infectious agents and disease 1995;4(3):131-42.
1995: James P Dunn; M W MacCumber; M S Forman; PATRICIA CHARACHE; LINDA APUZZO; Douglas A Jabs
Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir.
American journal of ophthalmology 1995;119(5):587-96.
1995: Douglas A Jabs
Ocular manifestations of HIV infection.
Transactions of the American Ophthalmological Society 1995;93():623-83.
1995: S Fekrat; James P Dunn; D Lee; T Miller; Douglas A Jabs
Cytomegalovirus retinitis in HIV-infected patients with elevated CD4+ counts.
Archives of ophthalmology 1995;113(1):18.
1994: N M Coskuncan; Douglas A Jabs; James P Dunn; Julia A Haller; W Richard Green; Georgia B Vogelsang; G W Santos
The eye in bone marrow transplantation. VI. Retinal complications.
Archives of ophthalmology 1994;112(3):372-9.
1994: Douglas A Jabs; R C Kuppers; AM Saboori; CAROL BUREK; C Enger; B Lee; Robert A Prendergast
Effects of early and late treatment with anti-CD4 monoclonal antibody on autoimmune disease in MRL/MP-lpr/lpr mice.
Cellular immunology 1994;154(1):66-76.
1994: Jennifer I Lim; Cheryl Enger; Julia A Haller; Peter A Campochiaro; Travis Meredith; S de Bustros; James P Dunn; Douglas A Jabs
Improved visual results after surgical repair of cytomegalovirus-related retinal detachments.
Ophthalmology 1994;101(2):264-9.
1994: Douglas A Jabs; Robert A Prendergast
Murine models of Sjögren's syndrome.
Advances in experimental medicine and biology 1994;350():623-30.
1993: James P Dunn; Douglas A Jabs; John R Wingard; Cheryl Enger; Georgia B Vogelsang; G Santos
Bone marrow transplantation and cataract development.
Archives of ophthalmology 1993;111(10):1367-73.
1992: Douglas A Jabs; CAROL BUREK; Q Hu; R C Kuppers; B Lee; Robert A Prendergast
Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/Mp-lpr/lpr mice.
Cellular immunology 1992;141(2):496-507.
1991: Douglas A Jabs; Robert A Prendergast
Autoimmune ocular disease in MRL/Mp-lpr/lpr mice is suppressed by anti-CD4 antibody.
Investigative ophthalmology & visual science 1991;32(10):2718-22.
1991: R Avery; Douglas A Jabs; John R Wingard; Georgia B Vogelsang; R Saral; G Santos
Optic disc edema after bone marrow transplantation. Possible role of cyclosporine toxicity.
Ophthalmology 1991;98(8):1294-301.
1991: Douglas A Jabs; Cheryl Enger; J Haller; S de Bustros
Retinal detachments in patients with cytomegalovirus retinitis.
Archives of ophthalmology 1991;109(6):794-9.
1991: Douglas A Jabs; Robert A Prendergast
Ocular inflammation in MRL/Mp-lpr/lpr mice.
Investigative ophthalmology & visual science 1991;32(6):1944-7.
1991: Douglas A Jabs; C Enger; Robert A Prendergast
Murine models of Sjögren's syndrome. Evolution of the lacrimal gland inflammatory lesions.
Investigative ophthalmology & visual science 1991;32(2):371-80.
1990: Henry D Jampel; Douglas A Jabs; Harry A Quigley
Trabeculectomy with 5-fluorouracil for adult inflammatory glaucoma.
American journal of ophthalmology 1990;109(2):168-73.
1989: Douglas A Jabs; John R Wingard; W Richard Green; Evan Farmer; Georgia B Vogelsang; R Saral
The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease.
Archives of ophthalmology 1989;107(9):1343-8.
1989: Joseph M Ahearn; J J Calomiris; Fredrick M Wigley; Douglas A Jabs; W B Bias; Marc C Hochberg
Characterization of the class I HLA 9.2-kb PVU II restriction fragment length polymorphism. Linkage to HLA-A and lack of disease association.
Arthritis and rheumatism 1989;32(7):870-6.
1989: Douglas A Jabs; W Richard Green; R Fox; B Frank Polk; John G Bartlett
Ocular manifestations of acquired immune deficiency syndrome.
Ophthalmology 1989;96(7):1092-9.
1989: D R Guyer; Douglas A Jabs; A M Brant; W E Beschorner; W Richard Green
Regression of cytomegalovirus retinitis with zidovudine. A clinicopathologic correlation.
Archives of ophthalmology 1989;107(6):868-74.
1989: Douglas A Jabs; Cheryl Enger; John G Bartlett
Cytomegalovirus retinitis and acquired immunodeficiency syndrome.
Archives of ophthalmology 1989;107(1):75-80.
1988: Douglas A Jabs; Robert A Prendergast
Murine models of Sjögren's syndrome. Immunohistologic analysis of different strains.
Investigative ophthalmology & visual science 1988;29(9):1437-43.
1988: Douglas A Jabs; A M Hanneken; A P Schachat; S L Fine
Choroidopathy in systemic lupus erythematosus.
Archives of ophthalmology 1988;106(2):230-4.
1987: Douglas A Jabs; Robert A Prendergast
Reactive lymphocytes in lacrimal gland and vasculitic renal lesions of autoimmune MRL/lpr mice express L3T4.
The Journal of experimental medicine 1987;166(4):1198-203.
1987: Douglas A Jabs; Cheryl L Newman; S De Bustros; B Frank Polk
Treatment of cytomegalovirus retinitis with ganciclovir.
Ophthalmology 1987;94(7):824-30.